Impairments in Walking Ability, Dexterity, and Cognitive Function in Multiple Sclerosis Are Associated with Different Regional Cerebellar Gray Matter Loss-Reference-Cited by-同舟云学术

Impairments in Walking Ability, Dexterity, and Cognitive Function in Multiple Sclerosis Are Associated with Different Regional Cerebellar Gray Matter Loss

Published:2017-06-13 Issue:5-6 Volume:16 Page:945-950
ISSN:1473-4222
Container-title:The Cerebellum
language:en
Short-container-title:Cerebellum

Author:

Grothe Matthias^ORCID,Lotze Martin,Langner Sönke,Dressel Alexander

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Neurology

Link

http://link.springer.com/article/10.1007/s12311-017-0871-8/fulltext.html

Reference40 articles.

1. Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372:1502–17.

2. Filippi M, Rocca MA, Barkhof F, et al. Association between pathological and MRI findings in multiple sclerosis. Lancet Neurol. 2012;11:349–60.

3. Kutzelnigg A, Lucchinetti CF, Stadelmann C, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain. 2005;128:2705–12.

4. Gilmore CP, Donaldson I, Bo L, Owens T, Lowe J, Evangelou N. Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord. J Neurol Neurosurg Psychiatry. 2009;80:182–7.

5. Deppe M, Tabelow K, Kramer J, et al. Evidence for early, non-lesional cerebellar damage in patients with multiple sclerosis: DTI measures correlate with disability, atrophy, and disease duration. Mult Scler. 2015;

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Betaine alleviates cerebellar endoplasmic reticulum stress and oxidative imbalance in a cuprizone model of multiple sclerosis in rat;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-09-09

2. Global Rearrangement of Degree Centrality Reflects Cognitive Impairment and Fatigue in Multiple Sclerosis;2024-03-15

3. Natalizumab reduces loss of gray matter and thalamic volume in patients with relapsing-remitting multiple sclerosis: A post hoc analysis from the randomized, placebo-controlled AFFIRM trial;Multiple Sclerosis Journal;2024-03-12

4. Association of Motor Function With Cognitive Trajectories and Structural Brain Differences;Neurology;2023-10-24

5. Tremor in Patients with Relapsing‐Remitting Multiple Sclerosis: Clinical Characteristics and Impact on Quality of Life;Movement Disorders Clinical Practice;2023-05-26